Skip to search.
 TSX Down 0.13% TSX Ventures Up 0.28%

Biogen Inc. (BIIB)

-NasdaqGS
282.79 Up 0.79(0.28%) May 27, 4:00PM EDT
Prev Close:282.00
Open:282.00
Bid:280.70 x 600
Ask:284.25 x 200
1y Target Est:345.50
Beta:0.3261
Earnings Date:Jul 22 - Jul 26 (Est.)
Day's Range:280.61 - 284.25
52wk Range:242.07 - 420.99
Volume:1,262,957
Avg Vol (3m):1,619,730
Market Cap:61.95B
P/E (ttm):17.38
EPS (ttm):16.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBUp 0.28%61.95B
PFEUp 0.52%209.90B
ABTUp 1.05%57.74B

Key Statistics

Forward P/E (1 yr):14.10
P/S (ttm):5.65
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :18.85
Quarterly EPS Est (Jun-16) :4.68
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.92

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback